When did CAMP4 Therapeutics (CAMP) last report earnings?

CAMP4 Therapeutics last reported on Aug 14, 2025, covering fiscal Q2 2025.

Did CAMP beat earnings estimates?

Yes. CAMP4 Therapeutics reported EPS of −$0.62 for Q2 2025 against a −$0.67 estimate — a 7.81% beat.

How much revenue did CAMP report last quarter?

CAMP4 Therapeutics reported $1.5M in revenue for Q2 2025, against a consensus estimate of $571,780.00.

CAMP4 Therapeutics (CAMP) earnings history

Most recent quarter

Fiscal period: Q2 2025
Period end: Jun 30, 2025
EPS actual: −$0.62
EPS estimate: −$0.67
EPS surprise: +7.81%
Revenue surprise: +161.81%
Revenue: $1.5M
Revenue estimate: $571,780.00
Reported: Aug 14, 2025
SEC filing: View filing

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q2 2025	Aug 14, 2025	−$0.67	−$0.62	+7.81%	$1.5M	SEC
Q1 2025	May 13, 2025	−$0.69	−$0.62	+10.64%	$858,000.00	SEC

Quarterly revenue

Q1 2025

$858,000.00

Q2 2025

$1.5M

Frequently asked questions

When did CAMP4 Therapeutics (CAMP) last report earnings?
CAMP4 Therapeutics last reported on Aug 14, 2025, covering fiscal Q2 2025.
Did CAMP beat earnings estimates?
Yes. CAMP4 Therapeutics reported EPS of −$0.62 for Q2 2025 against a −$0.67 estimate — a 7.81% beat.
How much revenue did CAMP report last quarter?
CAMP4 Therapeutics reported $1.5M in revenue for Q2 2025, against a consensus estimate of $571,780.00.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by